Reimbursement for genetic variant reinterpretation: five questions payers should ask.

Am J Manag Care

Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Box 357630, H375 Health Science Bldg, Seattle, WA 98195-7630. Email:

Published: October 2021

AI Article Synopsis

Article Abstract

Reaching the goals set by the Health Care Payment and Learning Action Network requires an unyielding and unrelenting focus on encouraging providers to adopt advanced alternative payment models (APMs). Many of these models will continue to be voluntary because they either are in early stages or have not yet proven their effectiveness. The models that have proven their effectiveness should become permanent, comprising the new way that providers are paid in the Medicare program. Either way, getting today's high performers into those programs and keeping them engaged to continue to innovate and set new benchmarks is as important as attracting and improving the performance of poorer performers. That will require a shift in Medicare's policy on pricing and evaluating APMs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430762PMC
http://dx.doi.org/10.37765/ajmc.2021.88763DOI Listing

Publication Analysis

Top Keywords

proven effectiveness
8
reimbursement genetic
4
genetic variant
4
variant reinterpretation
4
reinterpretation questions
4
questions payers
4
payers reaching
4
reaching goals
4
goals set
4
set health
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!